Condensed Consolidated Statements of Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Total Shareholders' Equity	Noncontrolling Interest
Beginning of period at Dec. 31, 2023		$ 1,439	$ 0	$ 2,580,968	$ (192,057)	$ 2,390,350	$ 1,063
Beginning of period (in shares) at Dec. 31, 2023		143,866
Increase (Decrease) in Equity [Roll Forward]
Shares issued under employee stock plans, net		$ 2	2,842
Shares issued under employee stock plans, net (in shares)		253
Shares repurchased under provisions of stock repurchase plan		$ (30)	(15,508)
Shares repurchased under provisions of stock repurchase plan				(348,301)
Shares repurchased under provisions of stock repurchase plan (in shares)		(3,000)
Stock compensation expense			12,372
Net earnings	$ 170,400			169,152			1,248
Other comprehensive income (loss)					(15,417)		(108)
Dividend and dividend equivalents paid			294	(294)
Distribution to noncontrolling interest							0
End of period at Mar. 31, 2024	2,197,665	$ 1,411	0	2,401,525	(207,474)	2,195,462	2,203
End of period (in shares) at Mar. 31, 2024		141,119
Beginning of period at Dec. 31, 2024	$ 2,225,784	$ 1,380	0	2,455,132	(233,500)	2,223,012	2,772
Beginning of period (in shares) at Dec. 31, 2024	138,003	138,003
Increase (Decrease) in Equity [Roll Forward]
Shares issued under employee stock plans, net		$ 3	12,531
Shares issued under employee stock plans, net (in shares)		282
Shares repurchased under provisions of stock repurchase plan		$ (15)	(24,124)
Shares repurchased under provisions of stock repurchase plan				(154,661)
Shares repurchased under provisions of stock repurchase plan (in shares)		(1,512)
Stock compensation expense			11,549
Net earnings	$ 204,099			203,795			304
Other comprehensive income (loss)	13,683				13,701		(18)
Dividend and dividend equivalents paid			44	(44)
Distribution to noncontrolling interest							(1,346)
End of period at Mar. 31, 2025	$ 2,287,503	$ 1,368	$ 0	$ 2,504,222	$ (219,799)	$ 2,285,791	$ 1,712
End of period (in shares) at Mar. 31, 2025	136,733	136,773